Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary intraocular lymphoma: A review.

John Y Choi1, Chrysanthi Kafkala, C Stephen Foster

  • 1Retina Specialists of Boston, Cambridge, MA, USA.

Seminars in Ophthalmology
|August 17, 2006
PubMed
Summary

Primary intraocular lymphoma (PIOL) is a rare eye cancer that often mimics other conditions, delaying diagnosis. Early detection via biopsy and prompt treatment with chemotherapy and radiation are crucial for managing this aggressive disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Saliva as a noninvasive diagnostic for ocular sarcoidosis.

Journal of leukocyte biology·2026
Same author

Oral cyclophosphamide as part of the treatment regimen in patients with nonparaneoplastic autoimmune retinopathy secondary to birdshot chorioretinopathy.

Oman journal of ophthalmology·2026
Same author

How to interpret low-dose valacyclovir for postherpetic neuralgia in the Zoster Eye Disease Study-a randomized clinical trial.

Annals of translational medicine·2026
Same author

CD8+ Regulatory T Cells.

Annual review of immunology·2025
Same author

Oral cyclophosphamide monotherapy in advanced resistant ocular cicatricial pemphigoid.

Taiwan journal of ophthalmology·2025
Same author

The Rate of Failure of Trabeculectomy and Tube Shunt Surgery in Eyes with Uveitic Glaucoma and Ocular Hypertension.

Ophthalmology. Glaucoma·2025

Area of Science:

  • Ophthalmology
  • Neurology
  • Oncology

Background:

  • Primary intraocular lymphoma (PIOL) is a subtype of primary central nervous system lymphoma (PCNSL).
  • It is the most frequent neoplastic masquerade syndrome affecting the eye.
  • Ocular symptoms and initial response to corticosteroids for presumed uveitis can delay diagnosis.

Purpose of the Study:

  • To highlight the diagnostic challenges of PIOL.
  • To outline current diagnostic and treatment strategies.
  • To discuss the prognosis and emerging therapies for PIOL.

Main Methods:

  • Emphasizes the need for a high index of suspicion.
  • Recommends tissue biopsy with cytology and ancillary studies for diagnosis.
  • Reviews current treatment protocols involving chemotherapy and radiation therapy.

Main Results:

  • Delayed diagnosis is common due to varied ocular presentations and initial misdiagnosis.
  • Tissue biopsy is essential for definitive diagnosis.
  • Current treatments include high-dose methotrexate chemotherapy and radiation therapy.

Conclusions:

  • Accurate and timely diagnosis of PIOL is critical.
  • Prognosis remains poor, often linked to central nervous system involvement.
  • Newer therapeutic approaches show promise in extending survival for PIOL patients.

Related Experiment Videos